Siglec-15 promotes progression of clear renal cell carcinoma

被引：4

作者：

Wen-Bo Yang

Cai-Peng Qin

Yi-Qing Du

Song-Chen Han

Tao Xu

机构：

[1] Beijing 100044

[2] ChinaDepartment of Urology

[3] Department of Urology

[4] Peking University People’s Hospital

来源：

中华医学杂志(英文版) | 2021年 / 134卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R737.11 [肾、肾盂肿瘤];

学科分类号：

100214 ;

摘要：

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, accounting for approximately 80% of cases. Although most patients in the early stages of ccRCC can be cured

引用

页码：2635 / 2637

页数：3

共 50 条

[11] Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression
Fan, Wen-Lang
Yeh, Yuan-Ming
Liu, Tsung-Ta
Lin, Wei-Ming
Yang, Tse-Yen
Lee, Chao-Wei
Lin, Tsung-Chieh
[J]. BIOMOLECULES, 2021, 11 (03) : 1 - 15
[12] CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma
Qi Lv
Gangmin Wang
Yinan Zhang
Aijun Shen
Junjun Tang
Yi Sun
Chunhui Ma
Peijun Wang
[J]. Journal of Experimental & Clinical Cancer Research, 40
[13] CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma
Lv, Qi
Wang, Gangmin
Zhang, Yinan
Shen, Aijun
Tang, Junjun
Sun, Yi
Ma, Chunhui
Wang, Peijun
[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
[14] Siglec-15 regulates cell proliferation, migration and invasion in bladder cancer
Gao, Han-Yuan
Liu, Guang-Jian
Qiu, Yan-Ru
[J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (04) : 1892 - 1894
[15] Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma
Chen, Xiaoting
Cai, Qian
Wong, Kaiyi
Shen, Ximing
Guan, Zhong
[J]. HELIYON, 2024, 10 (03)
[16] Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment
Wei, Xiyi
Wang, Yichun
Ji, Chengjian
Luan, Jiaocheng
Yao, Liangyu
Zhang, Xi
Wang, Shuai
Yao, Bing
Qin, Chao
Song, Ninghong
[J]. FRONTIERS IN GENETICS, 2021, 12
[17] RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
Liu, Yuenan
Cheng, Gong
Song, Zhengshuai
Xu, Tianbo
Ruan, Hailong
Cao, Qi
Wang, Keshan
Bao, Lin
Liu, Jingchong
Zhou, Lijie
Liu, Di
Yang, Hongmei
Chen, Ke
Zhang, Xiaoping
[J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (03) : 645 - 656
[18] VCAN promotes clear cell renal cell carcinoma tumor progression and metastasis, and predicts poor prognosis
Mitsui, Yozo
Kato, Taku
Maekawa, Shigekatsu
Hashimoto, Yutaka
Shiina, Marisa
Sumida, Mitsuho Imai
Wong, Ryan Kenji
Yamamura, Soichiro
Shahryari, Varahram
Majid, Shahana
Saini, Sharanjot
Deng, Guoren
Dahiya, Rajvir
Nakajima, Koichi
Tanaka, Yuichiro
[J]. CANCER RESEARCH, 2017, 77
[19] Normalization cancer immunotherapy: blocking Siglec-15!
Cao, Guangchao
Xiao, Zhiqiang
Yin, Zhinan
[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
[20] Normalization cancer immunotherapy: blocking Siglec-15!
Guangchao Cao
Zhiqiang Xiao
Zhinan Yin
[J]. Signal Transduction and Targeted Therapy, 4

← 1 2 3 4 5 →